Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockadeGRUNKE, M; SCHULZE-KOOPS, H.Annals of the rheumatic diseases. 2006, Vol 65, Num 4, pp 555-556, issn 0003-4967, 2 p.Article

In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseasesLORENZ, H.-M; GRÜNKE, M; HIERONYMUS, T et al.Arthritis and rheumatism. 1997, Vol 40, Num 2, pp 306-317, issn 0004-3591Article

Symptomatische chylöse präpatellare Bursitis nach Lymphographie = Symptomatic prepatellar bursitis after lymphographyGRÜNKE, M; GERLACH, A; KUGLER, V et al.RÖFO. Fortschritte auf dem Gebiete der Röntgenstrahlen und der neuen bildgebenden Verfahren. 1992, Vol 157, Num 6, pp 603-604, issn 0936-6652Article

Qualität einer interdisziplinären Sprechstunde in der Rheumaorthopädie = Quality of a multidisciplinary orthopaedic-rheumatological consultationMAYER-WAGNER, S; WIENDL, F; SCHEWE, S et al.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 8, pp 749-754, issn 0340-1855, 6 p.Article

Ein ungewöhnlicher Fall einer Heberden-Arthrose bei einem jungen Mann = An unusual case of Heberden nodes in a young manRASCU, A; KRAETSCH, H.-G; GRÜNKE, M et al.Zeitschrift für Rheumatologie (Print). 1999, Vol 58, Num 2, pp 95-99, issn 0340-1855Article

Neue Biologika und oral verfügbare neue Medikamente: Was ist noch in der Pipeline? : Was kommt nach TNF-Blockern im klinischen Alltag ? = New biologics and orally available compounds. What is still in the pipeline? : What comes after TNF-blockers in clinical routine ?GRÜNKE, M; BASTIAN, H; SCHULZE-KOOPS, H et al.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 7, issn 0340-1855, 626-632 [6 p.]Article

Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patientsVAN VAERENBERGH, K; HARRER, T; SCHMITT, M et al.AIDS research and human retroviruses. 2002, Vol 18, Num 6, pp 419-426, issn 0889-2229Article

In vivo blockade of tumor necrosis factor-α in patients with rheumatoid arthritis : Longterm effects after repeated infusion of chimeric monoclonal antibody cA2LORENZ, H.-M; GRÜNKE, M; HIERONYMUS, T et al.Journal of rheumatology. 2000, Vol 27, Num 2, pp 304-310, issn 0315-162XConference Paper

Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavirGRUNKE, M; VALERIUS, T; MANGER, B et al.Clinical infectious diseases. 1997, Vol 25, Num 5, pp 1270-1271, issn 1058-4838Article

Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosusLORENZ, H.-M; GRUNKE, M; WENDLER, J et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 10, pp 1517-1519, issn 0003-4967, 3 p.Article